Mapping inflammation onto mood: Inflammatory mediators of anhedonia.
about
Systemic inflammation enhances stimulant-induced striatal dopamine elevation.Elevated DNA Oxidation and DNA Repair Enzyme Expression in Brain White Matter in Major Depressive Disorder.A narrative literature review of depression following traumatic brain injury: prevalence, impact, and management challengesTherapeutic Implications of Brain-Immune Interactions: Treatment in Translation.Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy.Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines.Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models.Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans.Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.Role of physical exercise and omega-3 fatty acids on depressive illness in the elderly.Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination.Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.Peripheral TNFα elevations in abstinent alcoholics are associated with hepatitis C infection.Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.An active inference theory of allostasis and interoception in depression.
P2860
Q33601884-687D4F2F-005A-4C2E-ACF8-7F8F9F458579Q33623455-7312DBE8-BF28-4B90-9227-984FC329C048Q33813083-2BC09E33-BF21-4B97-BECB-C808A114350CQ38828405-DA3816FF-51F6-4B1F-B2A3-02797EF74EAFQ40156599-10A43CFF-0884-44A3-933C-CDD637D453F5Q47133496-7D9275D9-BC5A-4223-B2B8-1CCEB90C7544Q47148667-B87B8ECA-3228-4252-800A-689CAAB38CB4Q47318811-83A82280-08B5-42FA-8826-422E2BD3AC27Q47556460-2BDBE2DD-13F6-440D-86CC-349E1EC6D72AQ47623310-FF0282B2-BEDC-49EA-A385-7D291BAFAB65Q47667767-A81AF252-10BA-4147-B801-278C92D40D95Q47744143-232F5F04-519B-499D-B1CF-57F5B30F7DE4Q47830428-FA8D1B5E-0563-48F5-AA8D-8C44CBD97735Q48097218-F72D07EA-FB57-44A1-9022-A665FC9A5CB0Q50175494-C1588136-68F7-407F-BFBF-2F07F33E9DBDQ52108659-E0067538-8F06-4D6E-B7A9-BCC82496212A
P2860
Mapping inflammation onto mood: Inflammatory mediators of anhedonia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mapping inflammation onto mood: Inflammatory mediators of anhedonia.
@en
type
label
Mapping inflammation onto mood: Inflammatory mediators of anhedonia.
@en
prefLabel
Mapping inflammation onto mood: Inflammatory mediators of anhedonia.
@en
P1476
Mapping inflammation onto mood: Inflammatory mediators of anhedonia.
@en
P2093
Meriem Benlamri
Roger S McIntyre
P304
P356
10.1016/J.NEUBIOREV.2016.02.017
P577
2016-02-22T00:00:00Z